In the first clinical trial of its kind, people taking semaglutide drank less alcohol, adding to its promise of fighting addiction.

The cholesterol-lowering drug Lipobay (cerivastatin) was withdrawn last month by pharmaceutical giant Bayer. It has been linked with a number of deaths caused by a condition characterised by ...